Simple jQuery Dropdowns

Browsing by Author Annick Desjardins

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-Mar-2012Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patientsDavid A. Reardon; James E. Herndon; Katherine Peters; Annick Desjardins; April Coan; Emil Lou; Ashley Sumrall; Scott Turner; Sith Sathornsumetee; Jeremy N. Rich; Susan Boulton; Eric S. Lipp; Henry S. Friedman; James J. Vredenburgh; Dana-Farber Cancer Institute; Duke University School of Medicine; Mahidol University; Cleveland Clinic Foundation
1-Jul-2012Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant gliomaDavid A. Reardon; James J. Vredenburgh; Annick Desjardins; Katherine B. Peters; Sith Sathornsumetee; Stevie Threatt; John H. Sampson; James E. Herndon; April Coan; Frances McSherry; Jeremy N. Rich; Roger E. McLendon; Steven Zhang; Henry S. Friedman; Dana-Farber Cancer Institute; Duke University School of Medicine; Mahidol University; Cleveland Clinic Foundation; Bristol-Myers Squibb
1-Dec-2011Phase i study of sunitinib and irinotecan for patients with recurrent malignant gliomaDavid A. Reardon; James J. Vredenburgh; April Coan; Annick Desjardins; Katherine B. Peters; Sridharan Gururangan; Sith Sathornsumetee; Jeremy N. Rich; James E. Herndon; Henry S. Friedman; Duke University School of Medicine; Mahidol University; Cleveland Clinic Foundation
1-Oct-2012Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade gliomaDavid A. Reardon; Annick Desjardins; James J. Vredenburgh; James E. Herndon; April Coan; Sridharan Gururangan; Katherine B. Peters; Roger McLendon; Sith Sathornsumetee; Jeremy N. Rich; Eric S. Lipp; Dorothea Janney; Henry S. Friedman; Duke University; Mahidol University; Cleveland Clinic Foundation
1-Dec-2010Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant gliomaSith Sathornsumetee; Annick Desjardins; James J. Vredenburgh; Roger E. McLendon; Jennifer Marcello; James E. Herndon; Alyssa Mathe; Marta Hamilton; Jeremy N. Rich; Julie A. Norfleet; Sridharan Gururangan; Henry S. Friedman; David A. Reardon; Duke University School of Medicine; Cleveland Clinic Foundation; Mahidol University; OSI Pharmaceuticals Inc.